ClinicalTrials.Veeva

Menu

Impact of Implementation of an Enhanced Recovery After Surgery Program in Laparoscopic Roux-en-Y Gastric Bypass

H

Hospital General Universitario Elche

Status and phase

Unknown
Phase 3

Conditions

Postoperative Pain

Treatments

Combination Product: Standard care
Combination Product: ERAS protocol

Study type

Interventional

Funder types

Other

Identifiers

NCT03212573
HRJC17/18

Details and patient eligibility

About

A prospective randomized study of patients undergoing Roux-en-Y gastric bypass will be randomized in 2 groups: those following an ERAS program and those ones following a standard protocol.

Postoperative pain 24 hours after surgery and hospital stay will be assessed.

Full description

A prospective randomized study of patients undergoing Roux-en-Y gastric bypass will be randomized in 2 groups: those following an Enhanced Recovery After Surgery (ERAS) program and those ones following a standard protocol. The ERAS program implies early liquids oral intake, early deambulation and multimodal analgesia (port sites infiltration with Bupivacain 0.5% associated with intravenous analgesia).

Postoperative pain 24 hours after surgery, as measured by Visual Analogic Scale, and hospital stay will be assessed.

Enrollment

180 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Body Mass Index (BMI) >40 Kg/m2
  • BMI >35 Kg/m2 with obesity-associated comorbidities

Exclusion criteria

  • Patients undergoing other bariatric procedures
  • Patients undergoing bariatric revisional surgery

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

180 participants in 2 patient groups

ERAS protocol
Experimental group
Description:
ERAS protocol includes early oral intake (6 hours after surgery), early deambulation (6h after surgery) and multimodal analgesia (port-sites infiltration with Bupivacain 0.5% combined with postoperative intravenous analgesia)
Treatment:
Combination Product: ERAS protocol
Standard care
Active Comparator group
Description:
Oral intake and early deambulation begins 24h after surgery and analgesia consists in only intravenous drugs
Treatment:
Combination Product: Standard care

Trial contacts and locations

1

Loading...

Central trial contact

Alejandro Garcia; Jaime Ruiz-Tovar

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems